Literature DB >> 29966613

Illuminating the Black Box: The Real Risk of Serious Infection With Inflammatory Bowel Disease Therapies.

Amanda M Lynn1, Edward V Loftus2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29966613     DOI： 10.1053/j.gastro.2018.06.053

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  2 in total

Review 1.  Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Cristina Rubín de Célix; María Chaparro; Javier P Gisbert
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

2.  Long-term outcomes of antibiotic combination therapy for ulcerative colitis.

Authors:  Yuriko Nishikawa; Nobuhiro Sato; Shintaro Tsukinaga; Kan Uchiyama; Shigeo Koido; Dai Ishikawa; Toshifumi Ohkusa
Journal:  Ther Adv Chronic Dis       Date:  2021-07-06       Impact factor: 5.091
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.